| J3245 | Injection, tildrakizumab, 1 mg | 7,700 | $110 | $847K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,490 | $60 | $87.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 700 | $90 | $63.4K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 450 | $80 | $35.3K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 930 | $40 | $35.2K |
| J7308 | Aminolevulinic acid HCl for topical administration, 20%, single unit dosage form (354 mg) | 100 | $300 | $29.9K |
| 11102 | The provider biopsies a single skin lesion using a tangential (side–ways) approach; he shaves off the lesion or scoops it out with a knife or curette. | 440 | $70 | $29.2K |
| 96574 | This code is used to report removal of hyperkeratotic (hardened, dry, scaly) skin lesions that appear precancerous followed by photodynamic therapy that exposes a lesion treated with a… | 80 | $200 | $16.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 180 | $70 | $12.7K |
| 17262 | The provider destroys a malignant lesion on the trunk, arms, or legs using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. The malignant lesion is 1.1 cm to 2.0 cm in… | 70 | $130 | $8.9K |